Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Urb597 Abrogates Anxiogenic and Depressive Behaviors in the Methamphetamine-Withdrawal Mice: Role of the Cannabinoid Receptor Type 1, Cannabinoid Receptor Type 2, and Transient Receptor Potential Vanilloid 1 Channels Publisher Pubmed



Ebrahimighiri M1 ; Khakpai F2 ; Zarrindast MR3, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Biology, University of Zanjan, Zanjan, Iran
  2. 2. Cognitive and Neuroscience Research Center (CNRC), Islamic Azad University, Tehran, Iran
  3. 3. Department of Pharmacology, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Neuroendocrinology, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Psychopharmacology Published:2021


Abstract

Background: Methamphetamine is an addictive stimulant that possesses toxicity in the brain when taken repeatedly or at higher doses. Methamphetamine neurotoxicity is associated with numerous forms of mental impairment, including depression and anxiety. Evidence has also demonstrated that the endocannabinoid system is involved in the regulation of anxiety and depression. Aims: This study was designed to determine the involvement of the endocannabinoid system in anxiety- and depression-related behaviors in methamphetamine-withdrawal male NMRI mice. Methods: The elevated plus maze and forced swim test were used to assess the level of anxiety and depression. Results: We found that methamphetamine (30 mg/kg, intraperitoneal) evoked depressive- and anxiogenic-like effects at 3 days post-administration. Injection of URB597 (5–10 ng/mouse, intracerebroventricular), 10 min before the test, prevented the emotional deficits induced by methamphetamine withdrawal. Moreover, the cannabinoid receptor type 1 antagonist AM251 (1 μg/mouse) or cannabinoid receptor type 2 antagonist AM630 (5 and 10 μg/mouse) suppressed the antidepressant activity in the methamphetamine-withdrawal mice treated with URB597. The transient receptor potential vanilloid 1 antagonist capsazepine (25 μg/mouse) prevented while capsazepine (100 μg/mouse) potentiated the antidepressant efficacy in the methamphetamine-withdrawal mice treated with URB597. The higher dose of AM630 and two higher doses of capsazepine had antidepressant efficacy, by themselves. Furthermore, capsazepine (50 μg/mouse) increased locomotion in the methamphetamine-withdrawal mice treated with URB597. Conclusions: The results suggest that URB597 has a potential for preventing methamphetamine withdrawal-evoked anxiety and depression. Cannabinoid type 1 receptors, cannabinoid type 2 receptors and transient receptor potential vanilloid 1 differently affect depression-related behaviors in methamphetamine-withdrawal mice treated with URB597. © The Author(s) 2020.
Related Docs
View other Related Docs
1. The Effect of Urb597, Exercise or Their Combination on the Performance of 6-Ohda Mouse Model of Parkinson Disease in the Elevated Plus Maze, Tail Suspension Test and Step-Down Task, Metabolic Brain Disease (2021)
2. How Do Stupendous Cannabinoids Modulate Memory Processing Via Affecting Neurotransmitter Systems?, Neuroscience and Biobehavioral Reviews (2021)
3. Synergistic Antidepressant-Like Effect of Citicoline and Cb 1 Agonist in Male Mice, Psychopharmacology (2024)
4. Anxiolytic and Antidepressant Effects of Acpa and Harmaline Co-Treatment, Behavioural Brain Research (2019)
5. Antinociceptive and Antidepressive Efficacies of the Combined Ineffective Doses of S-Ketamine and Urb597, Naunyn-Schmiedeberg's Archives of Pharmacology (2019)
6. Precondition of Right Frontal Region With Anodal Tdcs Can Restore the Fear Memory Impairment Induced by Acpa in Male Mice, EXCLI Journal (2017)
7. Ketamine-Induced Antidepressant Like Effects in Mice: A Possible Involvement of Cannabinoid System, Biomedicine and Pharmacotherapy (2019)
8. Neurotransmission Systems in Parkinson's Disease, Reviews in the Neurosciences (2017)
Experts (# of related papers)
View all Related Experts
Ahmad Reza Dehpour (2)
Nima Rezaei (1)
Other Related Docs
9. Additive Anxiolytic-Like Effect of Citicoline and Acpa in the Non-Acute Restraint Stress (Nars) and Acute Restraint Stress (Ars) Mice, Physiology and Behavior (2024)
10. The Effect of Bla Gabaa Receptors in Anxiolytic-Like Effect and Aversive Memory Deficit Induced by Acpa, EXCLI Journal (2015)
11. Dorsal Hippocampal Nmda Receptors Mediate the Interactive Effects of Arachidonylcyclopropylamide and Mdma/Ecstasy on Memory Retrieval in Rats, Progress in Neuro-Psychopharmacology and Biological Psychiatry (2016)
12. Cannabinoids and Sleep-Wake Cycle: The Potential Role of Serotonin, Behavioural Brain Research (2021)
13. Combined Treatment of Scopolamine and Group Iii Mglur Antagonist, Cppg, Exerts Antidepressant Activity Without Affecting Anxiety-Related Behaviors, Physiology and Behavior (2020)
14. Involvement of Opioid System in Antidepressant-Like Effect of the Cannabinoid Cb1 Receptor Inverse Agonist Am-251 After Physical Stress in Mice, Clinical and Experimental Pharmacology and Physiology (2016)
15. Dorsal Hippocampal Cannabinergic and Gabaergic Systems Modulate Memory Consolidation in Passive Avoidance Task, Brain Research Bulletin (2018)
16. Endo-Cannabinoids System and the Toxicity of Cannabinoids With a Biotechnological Approach, EXCLI Journal (2017)
17. The Effects of Citalopram, Sb-334867 and Orexin-1, Alone or in Various Combinations, on the Anxiogenic-Like Effects of Rem Sleep Deprivation in Male Mice, Behavioural Pharmacology (2022)
18. Possible Interaction Between the Ventral Hippocampal Cannabinoid Cb2 and Muscarinic Acetylcholine Receptors on the Modulation of Memory Consolidation in Mice, NeuroReport (2020)
19. The Involvement of Medial Septum 5-Ht1 and 5-Ht2 Receptors on Acpa-Induced Memory Consolidation Deficit: Possible Role of Trpc3, Trpc6 and Trpv2, Journal of Psychopharmacology (2015)
20. Activation and Deactivation of 5-Ht1 Receptor of Accumbens Shell Area Does Not Alter Acpa-Induced Aversive Memory Deficit in Male Rat, Archives of Iranian Medicine (2017)
21. Interaction Between Nmda and Cb2 Function in the Dorsal Hippocampus on Memory Consolidation Impairment: An Isobologram Analysis, Psychopharmacology (2017)
22. Ligands for Cannabinoid Receptors, Promising Anticancer Agents, Life Sciences (2016)
23. Synergistic Effect Between Prelimbic 5-Ht3 and Cb1 Receptors on Memory Consolidation Deficit in Adult Male Sprague-Dawley Rats: An Isobologram Analysis, Neuroscience (2016)
24. Activation of Cannabinoid Receptors Elicits Antidepressant-Like Effects in a Mouse Model of Social Isolation Stress, Brain Research Bulletin (2017)
25. The Hippocampal Nmda Receptors May Be Involved in Acquisition, But Not Expression of Acpa-Induced Place Preference, Progress in Neuro-Psychopharmacology and Biological Psychiatry (2015)
26. Synergistic Antidepressant- and Anxiolytic-Like Effects of Harmaline Along With Cinanserin in Acute Restraint Stress-Treated Mice, Psychopharmacology (2021)
27. Additive Interaction Between Scopolamine and Nitric Oxide Agents on Immobility in the Forced Swim Test But Not Exploratory Activity in the Hole-Board, Psychopharmacology (2019)
28. Modulation of Cannabinoid Signaling by Hippocampal 5-Ht4 Serotonergic System in Fear Conditioning, Journal of Psychopharmacology (2016)
29. Antidepressive Synergism Between Crocin and D-Ap5 in Acute Restraint-Stressed Mice, Behavioural Pharmacology (2024)
30. Synergistic Antidepressant Effects of Citalopram and Sb-334867 in the Rem Sleep-Deprived Mice: Possible Role of Bdnf, Pharmacology Biochemistry and Behavior (2022)